Sorry, you need to enable JavaScript to visit this website.
Skip to main content


Dapagliflozin (Amorphous)

Therapeutic Category
Anti-Diabetic
API Technology
Synthetic
Dose From
Oral Solids
Dr Reddy's Development Status
Available
Available Regulatory Filing
USA
Korea
Europe
Innovator Brand (USA)
FARXIGA

We are here to help, if you have any country specific requirements - please Contact Us.